Picture of Chinook Therapeutics logo

KDNY — Chinook Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Brief: Chinook Therapeutics Reports Q4 Loss Per Share $1.24

April 7 (Reuters) - Chinook Therapeutics Inc  KDNY.O :
    * CHINOOK THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FOURTH
QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $1.24
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.41 -- REFINITIV IBES
DATA
    * CHINOOK THERAPEUTICS - CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES TOTALED $250.4 MILLION AT DECEMBER 31, 2020
    * CHINOOK THERAPEUTICS - EXPECT CASH POSITION TO FUND
OPERATIONS
TO MIDDLE OF 2023

Source text for Eikon:  ID:nGNXbcfspw 
Further company coverage:  KDNY.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Chinook Therapeutics

See all news